EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of a Chemical Probe to Enable Characterization of the Casein Kinase 1γ Subfamily

Jacob L Capener iD, Thomas W Kramer, Frances M Bashore iD, Emily Flory, Fengling Li, Blair L Strang, Alison D Axtman iD

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.5c02609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Jacob L Capener und 6 weiteren Autor:innen. Beteiligte Einrichtung: Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, Unit…. Hauptthemen laut MEDLINE: Casein Kinase I, Protein Kinase Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The casein kinase 1γ (CK1γ) subfamily, while severely understudied, is implicated in diverse disease-relevant pathways, including WNT signaling and human cytomegalovirus (HCMV) replication. While genetic tools exist to study CK1γ, the selective inhibition of CK1γ through pharmacological means remains underexplored. Chemical probes, or potent and selective inhibitors, remain one of the most powerful pharmacological tools for uncovering protein biology. Herein, we developed several novel assays for assessing target engagement with the CK1γ subfamily in cells. Enabled by these assays, we conducted a comprehensive structure-activity relationship (SAR) campaign to develop the first chemical probe, SGC-CK1γ-1, for the CK1γ subfamily. SGC-CK1γ-1, which was developed alongside a structurally related negative control compound, potently and selectively inhibited the CK1γ kinases in living cells, plus inhibited both WNT signaling and human cytomegalovirus replication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Casein Kinase IProtein Kinase InhibitorsHumansStructure-Activity RelationshipCytomegalovirusVirus ReplicationWnt Signaling Pathway

Substanzen

Casein Kinase IProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
  • Institute for Infection & Immunity, City St George's, University of London, London SW17 0RE, U.K.

ORCID-Profile: Jacob L Capener, Frances M Bashore, Alison D Axtman

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIDDK NIH HHS
  • NIA NIH HHS
  • National Cancer Institute
  • NIH Office of the Director
  • Bayer
  • Merck KGaA

Zitieren

APA

Capener, J. L., Kramer, T. W., Bashore, F. M., Flory, E., Li, F., Strang, B. L., & Axtman, A. D. (2026). Development of a Chemical Probe to Enable Characterization of the Casein Kinase 1γ Subfamily. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02609

Vancouver

Capener JL, Kramer TW, Bashore FM, Flory E, Li F, Strang BL, et al. Development of a Chemical Probe to Enable Characterization of the Casein Kinase 1γ Subfamily. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c02609

BibTeX
@article{Capener2026,
  author = {Capener, Jacob L and Kramer, Thomas W and Bashore, Frances M and Flory, Emily and Li, Fengling and Strang, Blair L and Axtman, Alison D},
  title = {Development of a Chemical Probe to Enable Characterization of the Casein Kinase 1γ Subfamily},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.5c02609}
}
Kostenlos starten →